Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study

被引:0
|
作者
Barbora Mikulášková
Martina Holubová
Veronika Pražienková
Jana Zemenová
Lucie Hrubá
Martin Haluzík
Blanka Železná
Jaroslav Kuneš
Lenka Maletínská
机构
[1] Institute of Organic Chemistry and Biochemistry AS CR,Centre for Experimental Medicine and Diabetes Centre
[2] Institute of Physiology AS CR,Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine
[3] University of Chemistry and Technology,undefined
[4] Institute for Clinical and Experimental Medicine,undefined
[5] Charles University in Prague and General University Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 6 条
  • [1] Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study
    Mikulaskova, Barbora
    Holubova, Martina
    Prazienkova, Veronika
    Zemenova, Jana
    Hruba, Lucie
    Haluzik, Martin
    Zelezna, Blanka
    Kunes, Jaroslav
    Maletinska, Lenka
    NUTRITION & DIABETES, 2018, 8
  • [2] Cytochemical study of prolactin-releasing peptide (PrRP) in the rat brain
    Iijima, N
    Kataoka, Y
    Kakihara, K
    Bamba, H
    Tamada, Y
    Hayashi, S
    Matsuda, T
    Tanaka, M
    Honjyo, H
    Hosoya, W
    Hinuma, S
    Ibata, Y
    NEUROREPORT, 1999, 10 (08) : 1713 - 1716
  • [3] Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats
    Cermakova, Martina
    Pelantova, Helena
    Neprasova, Barbora
    Sediva, Blanka
    Maletinska, Lenka
    Kunes, Jaroslav
    Tomasova, Petra
    Zelezna, Blanka
    Kuzma, Marek
    JOURNAL OF PROTEOME RESEARCH, 2019, 18 (04) : 1735 - 1750
  • [4] The role of I1-imidazoline and α2-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X
    Velliquette, RA
    Ernsberger, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (02): : 646 - 657
  • [5] GLUCOSE-TOLERANCE IS IMPROVED IN THE SPONTANEOUSLY-HYPERTENSIVE RAT (SHR) BY ETHYL-2-(6-(4-CHLOROPHENOXYL)-HEXYL)OXIRANE-2-CARBOXYLATE (ETOMOXIR), AN INHIBITOR OF FATTY-ACID OXIDATION
    SWISLOCKI, A
    EASON, T
    CLINICAL RESEARCH, 1993, 41 (01): : A65 - A65
  • [6] GLUCOSE-TOLERANCE AND BLOOD-PRESSURE ARE IMPROVED IN THE SPONTANEOUSLY HYPERTENSIVE RAT BY ETHYL-2-(6-(4-CHLOROPHENOXY)-HEXYL)OXIRANE-2-CARBOXYLATE (ETOMOXIR), AN INHIBITOR OF FATTY-ACID OXIDATION
    SWISLOCKI, A
    EASON, T
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (08) : 739 - 744